Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Prostate Cancer

Clinical trial condition

Metastatic Prostate Cancer

Explore clinical trials studying Metastatic Prostate Cancer. Study availability and eligibility vary by location and protocol.

136 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Prostate Cancer trial results

Recruiting

68Ga-PSMA PET/CT for Ra223 Assessment

NCT04951817

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Chang Gung Memorial Hospital ,Linkou Taoyuan City, Taiwan

View Trial Details

Recruiting

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

NCT06738303

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

NCT05885009

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: SOLTI Cancer Research Group Barcelona, Spain

View Trial Details

Recruiting

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

NCT07032584

Conditions: Androgen Deprivation Therapy, Genital Diseases, Genital Diseases, Male, +10 more
Locations: University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Recruiting

TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer

NCT05582772

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: St. Michael's hospital Toronto, Ontario, Canada

University Health Network - Princess Margaret Cancer Centre Toronto, Ontario, Canada

Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Measuring Oncological Value of Exercise and Statin

NCT05796973

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +42 more
Locations: Tampere University Hospital Tampere, Länsi-Suomi, Finland

View Trial Details

Recruiting

PRostate Cancer Plasma Integrative Multi-modal Evaluation

NCT06981377

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Istituto Romagnolo per lo Studio dei Tumori Meldola, Forlì-Cesena, Italy

Azienda Ospedaliera San Luigi Orbassano, Torino, Italy

Istituto Oncologico Veneto Padova, Italy

Santa Chiara Hospital Trento, Italy

View Trial Details

Recruiting

A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

NCT06782555

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +22 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

NCT06582628

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Institut Català d'Oncologia (ICO) Badalona, Barcelona, Spain

Consorcio Corporación Sanitaria Parc Taulí Sabadell, Barcelona, Spain

Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain

Hospital Universitario de Jerez de la Frontera Cadiz, Cádiz, Spain

View Trial Details

Recruiting

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

NCT06706921

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations: VA Greater Los Angeles Healthcare System Los Angeles, California, United States

View Trial Details